Cite

HARVARD Citation

    Brinson, R. et al. (2019). Enabling adoption of 2D-NMR for the higher order structure assessment of monoclonal antibody therapeutics. MAbs. 11 (1), pp. 94-105. [Online]. 
  
Back to record